Inmune Bio Inc (INMB) Live Share Price, Invest From India

Inmune Bio Inc Stock Performance

as on January 27, 2026 at 2:29 am IST

Day's Low
Day's High
$1.63
Day's Price Range
$1.70
$1.67
2.40%
Downside
1.80%
Upside
52 Week's Low
52 Week's High
$1.38
52-Week Price Range
$11.64
$1.67
17.37%
Downside
597.01%
Upside

Inmune Bio Inc share price movements today

Previous Close: $1.70
Open: $1.67
Volume: 596.0K
Day's Low - High: $1.63 - $1.70
52 Week Low - High: $1.38 - $11.64

Inmune Bio Inc Historical Returns

1 Month Return: -3.47 %
3 Month Return: -9.24 %
1 Year Return: -78.89 %
3 Year Return: -80 %
5 Year Return: 0 %

Inmune Bio Inc Stock Fundamentals & Key Indicators

Check Inmune Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$45.2M

EPS (TTM)

-1.375

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.59

Industry PE ratio

-2.8168481375358168

PEG Ratio

EBITDA

Revenue (TTM)

50.0K

Profit Margin

0.00%

Return On Equity TTM

-155.77%

Inmune Bio Inc Stock Valuation

Track how Inmune Bio Inc P/E has moved over time to understand its valuation trends.

Inmune Bio Inc in the last 5 years

Overview
Trends

Lowest (-12.33x)

September 30, 2021

Today (-3.59x)

January 27, 2026

Industry (-2.82x)

January 27, 2026

Highest (-1.62x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -3.59x

Inmune Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Inmune Bio Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Inmune Bio Inc	BUY	$45.2M	NA	-3.59	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$47.3B	132.54%	1234.41	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$120.1B	111.69%	33.01	31.35%
Beone Medicines Ltd	NA	$37.5B	NA	665.33	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$79.9B	47.93%	18.05	32.13%

Stock Returns calculator for Inmune Bio Inc Stock including INR - Dollar returns

The Inmune Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Inmune Bio Inc investment value today

Current value as on today

₹27,158

Returns

₹72,842

(-72.84%)

Returns from Inmune Bio Inc Stock

₹78,887 (-78.89%)

Dollar Returns*

₹6,046 (+6.05%)

Analyst Recommendation on Inmune Bio Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Inmune Bio Inc. Average target price of $5.25

Inmune Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Inmune Bio Inc.

What analysts predicted

68.19%UPSIDE

Target Price

$5.25

Current Price

$1.67

Analyzed by

9 Analysts

Target

$5.25

Inmune Bio Inc target price $5.25, a slight upside of 68.19% compared to current price of $1.67. According to 9 analysts rating.

Inmune Bio Inc Stock’s Investor Sentiment and Interest

Search interest for Inmune Bio Inc Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: December 28, 2025 to January 27, 2026

Change:12% versus previous 30 day period

Inmune Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	0	0	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	-	-	-	0	-	0
Operating Income	-6	-8	-8	-11	-9	-12	-9	-9	-24	-7
EBITDA	-6	-8	-8	-11	-9	-12	-9	-9	-8	-6
Interest Expense	-	-	0	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-6	-8	-8	-11	-9	-12	-9	-9	-24	-6
Income Tax Expense	-6	-8	14	-11	-9	-	-	-	-	-
Net Income	-6	-8	-8	-11	-9	-12	-9	-9	-24	-6
Net Profit Margin	-14132.61%	-19913.95%	-30028.57%	-78750.00%	0.00%	0.00%	0.00%	-19478.00%	0.00%	0.00%

Inmune Bio Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	77	0	0	0	0	0
Gross Profit	-	-	-	-	77	0	0	0	0	0
Operating Income	0	0	0	-12	-7	-12	-29	-25	-29	-42
EBITDA	0	0	0	-12	-7	-12	-30	-27	-29	-42
Interest Expense	-	-	-	-	-	-	1	1	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	0	0	0	-12	-7	-12	-30	-27	-30	-42
Income Tax Expense	-	0	-1	0	1	0	1	1	-29	-
Net Income	0	0	0	-12	-7	-12	-30	-28	-30	-42
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-9.88%	-110838.76%	-16762.43%	-7659.63%	-19360.00%	-300585.71%

Inmune Bio Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-8	-8	-11	-9	-12	-9	-9	-24	-6
Operating Cash Flow	-4	-3	-7	-7	-6	-11	-6	-7	-5
Investing Cash Flow	-2	2	-	-	-	-	-	0	0
Financing Cash Flow	-1	-2	-2	12	9	-2	5	22	-
Change in Cash	-6	-5	-9	5	2	-12	-1	14	-5

Inmune Bio Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	0	-12	-7	-12	-30	-27	-30	-42
Operating Cash Flow	0	-2	-5	-8	-28	-22	-11	-33
Investing Cash Flow	0	-15	-15	-15	-15	-	-	-
Financing Cash Flow	2	0	12	23	96	0	-4	18
Change in Cash	1	-1	6	14	52	-22	-16	-14

Global Institutional Holdings in Inmune Bio Inc

Funds	Holdings
Vanguard Group Inc	3.19%
UBS Group AG	1.69%
Rhenman Partners Asset Management AB	0.67%
SIMPLEX TRADING, LLC	0.26%
Charles Schwab Investment Management Inc	0.19%

See all

Insights on Inmune Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 14.0K → 50.0K (in $), with an average increase of 72.0% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -24.45M → -6.47M (in $), with an average increase of 277.9% per quarter
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 50.6% return, outperforming this stock by 129.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 30.6% return, outperforming this stock by 110.2%
NEGATIVE IMPACT
Price Dip
In the last 1 year, INMB stock has moved down by -78.5%

About Inmune Bio Inc

inmune bio inc. is a clinical stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. inkmune, the company’s lead product, primes patient’s nk cells (natural killer cells) to kill cancer. inmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. by controlling residual disease, patients may live longer. using a novel mechanism of action and a precision medicine approach, inkmune therapy should enhance nk cells’ ability to eliminate residual disease.

Organisation	Inmune Bio Inc
Headquarters	225 NE Mizner Blvd., Boca Raton, FL, United States, 33432
Industry	Medical Specialties
CEO	Mr. David J. Moss M.B.A.
E-voting on shares	Click here to vote

Key Management of Inmune Bio Inc

Name	Title
Mr. David J. Moss M.B.A.	President, CEO, Treasurer, Secretary & Director
Dr. Mark William Lowdell Ph.D.	Chief Scientific Officer & Chief Manufacturing Officer
Mr. Cory Randall Ellspermann	Interim Chief Financial Officer
Mr. Daniel Frederick Carlson	Head of Investor Relations
Mr. Joshua S. Schoonover Esq.	General Counsel

FAQs

What is Inmune Bio Inc share price today?

Inmune Bio Inc share price today is $1.67 as on January 27, 2026 at 2:29 am IST at the close of the market. Inmune Bio Inc share today touched a day high of $1.7 and a low of $1.63.

What is the 52 week high and 52 week low for Inmune Bio Inc share?

Inmune Bio Inc share touched a 52 week high of $11.64 on June 27, 2025 and a 52 week low of $1.38 on November 14, 2025. Inmune Bio Inc stock price today i.e. January 27, 2026 at 2:29 am IST is closed at $1.67,which is 85.65% down from its 52 week high and 21.01% up from its 52 week low.

What is Inmune Bio Inc's market capitalisation today?

Inmune Bio Inc market capitalisation is $0.00T as on January 27, 2026 at 2:29 am IST.

How to invest in Inmune Bio Inc Stock (INMB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Inmune Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inmune Bio Inc Shares that will get you 0.8982 shares as per Inmune Bio Inc share price of $1.67 per share as on January 27, 2026 at 2:29 am IST.

What is the minimum amount required to buy Inmune Bio Inc Stock (INMB) from India?

Indian investors can start investing in Inmune Bio Inc (INMB) shares with as little as ₹91.581 or $1 (as of January 27, 2026 at 9:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹915.81 in Inmune Bio Inc stock (as per the Rupee-Dollar exchange rate as on January 27, 2026 at 9:37 am IST). Based on Inmune Bio Inc share’s latest price of $1.67 as on January 27, 2026 at 2:29 am IST, you will get 5.9880 shares of Inmune Bio Inc. Learn more about fractional shares .